MOXIPEN CAPSULE 250 mg
Product details
Registration number: SIN06951P
Classification: Prescription Only
Active ingredients: AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
Strength: 250 mg
Dosage form: CAPSULE
Route: ORAL
Registrant: APEX PHARMA MARKETING PTE. LTD.
ATC code: J01CA04
HSA approval date: 13 April 1992
Manufacturer(s): XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Manufacturing country/countries: MALAYSIA
What are the HSA registration number and classification for MOXIPEN CAPSULE 250 mg?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN06951P
Classification: Prescription Only
What active ingredients and strength are recorded for MOXIPEN CAPSULE 250 mg?
According to the HSA dataset updated 7 August 2026:
Active ingredients: AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN
Strength: 250 mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for MOXIPEN CAPSULE 250 mg?
According to the HSA dataset updated 7 August 2026:
Dosage form: CAPSULE
Route: ORAL
Who is the recorded registrant for MOXIPEN CAPSULE 250 mg?
According to the HSA dataset updated 7 August 2026:
Registrant: APEX PHARMA MARKETING PTE. LTD.
Which manufacturers and countries are listed for MOXIPEN CAPSULE 250 mg?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Manufacturing country/countries: MALAYSIA
Where can I look up MOXIPEN CAPSULE 250 mg in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN06951P or the exact product name MOXIPEN CAPSULE 250 mg. The general register link does not preselect this product.
What are the source dates for this MOXIPEN CAPSULE 250 mg record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this MOXIPEN CAPSULE 250 mg record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN06951P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)